Amphastar Pharmaceuticals (AMPH) Earnings Date & Reports

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

AMPH is expected to report earnings to fall 24.57% to 69 cents per share on May 07

Amphastar Pharmaceuticals AMPH Stock Earnings Reports

Q1'25

Est.

$0.69

Q4'24

Missed

by $0.05

Q3'24

Missed

by $0.04

Q2'24

Beat

by $0.17

Q1'24

Beat

by $0.26

The last earnings report on February 27 showed earnings per share of 92 cents, missing the estimate of 97 cents. With 235.29K shares outstanding, the current market capitalization sits at 2.11B.

View a ticker or compare two or three

Compare

AMPH